TD Cowen Reiterates Buy Rating on Vertex (VRTX): 'VRTX is a Top 2025 L.C. Biotech Pick'
Tweet Send to a Friend
TD Cowen analyst Phil Nadeau reiterated a Buy rating and $525.00 price target on Vertex (NASDAQ: VRTX). Stock named top ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
